ID 1433B_BOVIN Reviewed; 246 AA. AC P68250; P29358; Q0VCL1; DT 25-OCT-2004, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 22-FEB-2023, entry version 124. DE RecName: Full=14-3-3 protein beta/alpha; DE AltName: Full=Protein kinase C inhibitor protein 1; DE Short=KCIP-1; DE Contains: DE RecName: Full=14-3-3 protein beta/alpha, N-terminally processed; GN Name=YWHAB; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG). RC STRAIN=Hereford; TISSUE=Fetal pons; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases. RN [2] RP PROTEIN SEQUENCE OF 2-246. RX PubMed=1671102; DOI=10.1016/0022-2836(91)90616-e; RA Isobe T., Ichimura T., Sunaya T., Okuyama T., Takahashi N., Kuwano R., RA Takahashi Y.; RT "Distinct forms of the protein kinase-dependent activator of tyrosine and RT tryptophan hydroxylases."; RL J. Mol. Biol. 217:125-132(1991). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT). RA Jones J.M., Niikura T., Pinke R.M., Guo W., Molday L., Leykam J., RA McConnell D.G.; RT "Expression of 14-3-3 proteins in bovine retinal photoreceptors."; RL Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases. RN [4] RP FUNCTION. RX PubMed=7931346; DOI=10.1046/j.1471-4159.1994.63051908.x; RA Tanji M., Horwitz R., Rosenfeld G., Waymire J.C.; RT "Activation of protein kinase C by purified bovine brain 14-3-3: comparison RT with tyrosine hydroxylase activation."; RL J. Neurochem. 63:1908-1916(1994). CC -!- FUNCTION: Adapter protein implicated in the regulation of a large CC spectrum of both general and specialized signaling pathways. Binds to a CC large number of partners, usually by recognition of a phosphoserine or CC phosphothreonine motif. Binding generally results in the modulation of CC the activity of the binding partner. Negative regulator of CC osteogenesis. Blocks the nuclear translocation of the phosphorylated CC form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on CC cyclin D1 expression resulting in blockage of neuronal apoptosis CC elicited by SRPK2. Negative regulator of signaling cascades that CC mediate activation of MAP kinases via AKAP13. CC {ECO:0000250|UniProtKB:P31946, ECO:0000269|PubMed:7931346}. CC -!- SUBUNIT: Homodimer (By similarity). Interacts with SAMSN1 and PRKCE (By CC similarity). Interacts with AKAP13. Interacts with SSH1 and CC TORC2/CRTC2. Interacts with ABL1; the interaction results in CC cytoplasmic location of ABL1 and inhibition of cABL-mediated apoptosis. CC Interacts with ROR2 (dimer); the interaction results in phosphorylation CC of YWHAB on tyrosine residues. Interacts with GAB2. Interacts with YAP1 CC (phosphorylated form). Interacts with the phosphorylated (by AKT1) form CC of SRPK2. Interacts with PKA-phosphorylated AANAT. Interacts with CC MYO1C. Interacts with SIRT2 (By similarity). Interacts with the 'Thr- CC 369' phosphorylated form of DAPK2 (By similarity). Interacts with CC PI4KB, TBC1D22A and TBC1D22B. Interacts with the 'Ser-1134' and 'Ser- CC 1161' phosphorylated form of SOS1 (By similarity). Interacts (via CC phosphorylated form) with YWHAB; this interaction occurs in a protein CC kinase AKT1-dependent manner (By similarity). Interacts with SLITRK1. CC Interacts with SYNPO2 (phosphorylated form); YWHAB competes with ACTN2 CC for interaction with SYNPO2 (By similarity). Interacts with RIPOR2 (via CC phosphorylated form); this interaction occurs in a chemokine-dependent CC manner and does not compete for binding of RIPOR2 with RHOA nor blocks CC inhibition of RIPOR2-mediated RHOA activity (By similarity). Interacts CC with MARK2 and MARK3 (By similarity). Interacts with TESK1; the CC interaction is dependent on the phosphorylation of TESK1 'Ser-439' and CC inhibits TESK1 kinase activity (By similarity). Interacts with MEFV (By CC similarity). Interacts with HDAC4 (By similarity). Interacts with CC ADAM22 (via C-terminus) (By similarity). {ECO:0000250|UniProtKB:P31946, CC ECO:0000250|UniProtKB:Q9CQV8}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P31946}. CC Melanosome {ECO:0000250|UniProtKB:P31946}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative initiation; Named isoforms=2; CC Comment=It is uncertain whether isoform Short is produced by CC alternative initiation or another biological event.; CC Name=Long; CC IsoId=P68250-1; Sequence=Displayed; CC Name=Short; CC IsoId=P68250-2; Sequence=VSP_018631; CC -!- PTM: The alpha, brain-specific form differs from the beta form in being CC phosphorylated. Phosphorylated on Ser-60 by protein kinase C delta type CC catalytic subunit in a sphingosine-dependent fashion. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC120112; AAI20113.1; -; mRNA. DR EMBL; AF043736; AAC02090.1; -; mRNA. DR PIR; S13467; S13467. DR RefSeq; NP_777219.2; NM_174794.2. DR AlphaFoldDB; P68250; -. DR SMR; P68250; -. DR STRING; 9913.ENSBTAP00000022411; -. DR iPTMnet; P68250; -. DR PaxDb; P68250; -. DR PeptideAtlas; P68250; -. DR GeneID; 286863; -. DR KEGG; bta:286863; -. DR CTD; 7529; -. DR eggNOG; KOG0841; Eukaryota. DR HOGENOM; CLU_058290_1_0_1; -. DR InParanoid; P68250; -. DR OrthoDB; 920089at2759; -. DR TreeFam; TF102003; -. DR Proteomes; UP000009136; Unplaced. DR GO; GO:0005737; C:cytoplasm; ISS:AgBase. DR GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell. DR GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:AgBase. DR GO; GO:0019904; F:protein domain specific binding; ISS:AgBase. DR GO; GO:0004860; F:protein kinase inhibitor activity; ISS:UniProtKB. DR GO; GO:0045744; P:negative regulation of G protein-coupled receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0006605; P:protein targeting; ISS:AgBase. DR GO; GO:0007165; P:signal transduction; IBA:GO_Central. DR CDD; cd10022; 14-3-3_beta_zeta; 1. DR Gene3D; 1.20.190.20; 14-3-3 domain; 1. DR InterPro; IPR000308; 14-3-3. DR InterPro; IPR023409; 14-3-3_CS. DR InterPro; IPR036815; 14-3-3_dom_sf. DR InterPro; IPR023410; 14-3-3_domain. DR PANTHER; PTHR18860; 14-3-3 PROTEIN; 1. DR PANTHER; PTHR18860:SF28; 14-3-3 PROTEIN BETA/ALPHA; 1. DR Pfam; PF00244; 14-3-3; 1. DR PIRSF; PIRSF000868; 14-3-3; 1. DR PRINTS; PR00305; 1433ZETA. DR SMART; SM00101; 14_3_3; 1. DR SUPFAM; SSF48445; 14-3-3 protein; 1. DR PROSITE; PS00796; 1433_1; 1. DR PROSITE; PS00797; 1433_2; 1. PE 1: Evidence at protein level; KW Acetylation; Alternative initiation; Cytoplasm; Direct protein sequencing; KW Isopeptide bond; Nitration; Phosphoprotein; Reference proteome; KW Ubl conjugation. FT CHAIN 1..246 FT /note="14-3-3 protein beta/alpha" FT /id="PRO_0000367899" FT INIT_MET 1 FT /note="Removed; alternate" FT /evidence="ECO:0000250|UniProtKB:P31946, FT ECO:0000269|PubMed:1671102" FT CHAIN 2..246 FT /note="14-3-3 protein beta/alpha, N-terminally processed" FT /id="PRO_0000000001" FT SITE 58 FT /note="Interaction with phosphoserine on interacting FT protein" FT /evidence="ECO:0000250" FT SITE 129 FT /note="Interaction with phosphoserine on interacting FT protein" FT /evidence="ECO:0000250" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:P31946" FT MOD_RES 2 FT /note="N-acetylthreonine; in 14-3-3 protein beta/alpha, N- FT terminally processed" FT /evidence="ECO:0000250|UniProtKB:P31946" FT MOD_RES 2 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P31946" FT MOD_RES 5 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P27348" FT MOD_RES 51 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P27348" FT MOD_RES 60 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9CQV8" FT MOD_RES 70 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P31946" FT MOD_RES 84 FT /note="3'-nitrotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q9CQV8" FT MOD_RES 106 FT /note="3'-nitrotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q9CQV8" FT MOD_RES 117 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P31946" FT MOD_RES 186 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P68251" FT MOD_RES 232 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P31946" FT CROSSLNK 51 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2); alternate" FT /evidence="ECO:0000250|UniProtKB:P27348" FT VAR_SEQ 1..2 FT /note="Missing (in isoform Short)" FT /evidence="ECO:0000303|Ref.3" FT /id="VSP_018631" FT CONFLICT 101 FT /note="Q -> E (in Ref. 1; AAI20113)" FT /evidence="ECO:0000305" FT MOD_RES P68250-2:1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250" SQ SEQUENCE 246 AA; 28081 MW; CABA32314D86800D CRC64; MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL QLLDKYLIPN ATQPESKVFY LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD AGEGEN //